In 2020, I lost 65 pounds
In essence, Retatrutide tackles three metabolic pathways at once, resulting in greater efficacy in lowering blood glucose and body fat than single- or dual-agonist therapies
Insilico Medicines AI Drug for IPF Progresses to Phase III Trials To view or add a comment, sign in A noteworthy study led by Mingliang Liu and colleagues, with major contributions from researchers at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and collaborating institutions, highlights how rational structural optimization can transform an active FXR agonist into a clinically advanced drug candidate
Individual variability in response to retatrutide is well recognised in clinical research
Patients also face tough choices
Most people inject retatrutide once per week on the same day